Biovo

Company Overview

Snapshot

Founded in January 2011 by Oron Zachar and Adam Kima, Biovo operated with 1–10 employees. The company ceased operations in April 2023.

Business overview

Biovo develops, manufactures, and markets medical devices designed to address clinical needs in intensive care units, operating rooms, and anesthesia care. Its product portfolio includes Cuffix, a disposable cuff pressure monitor and stabilizer for mechanically ventilated patients; B-Care, an oral care kit for ICU patients; and HyperFlex-LM, a laryngeal mask for anesthesia. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Life Support, serving healthcare providers globally.

Strategic signal

In April 2023, Biovo ceased operations. This indicates a significant shift in the company's trajectory, signaling to investors and innovation teams that the company is no longer an active entity in the critical care device market.

Company Intelligence Q&A

What is Biovo's operational status?

Biovo is currently non-active, having ceased operations in April 2023.

When was Biovo founded and by whom?

Biovo was founded in January 2011 by Oron Zachar and Adam Kima.

What is Biovo's primary focus in the medical device market?

Biovo develops, manufactures, and markets devices for critical care units, operating rooms, and anesthesia, addressing unmet clinical needs in these areas.

What products does Biovo offer for critical care?

Biovo offers products such as Cuffix, a cuff pressure monitor for ventilated patients; B-Care, an oral care kit for ICU patients; and HyperFlex-LM, a laryngeal mask for anesthesia.

What was a key product launch for Biovo?

In September 2019, Biovo launched an innovative anesthesia and ventilation platform at The American Association for Respiratory Care (AARC) Conference.